Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 73
Filtrar
Más filtros

Medicinas Complementárias
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Nutr Health Aging ; 22(4): 491-500, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29582888

RESUMEN

OBJECTIVES: This study aimed to assess the effect of 25-hydroxyvitamin D3 (25OHD) which is a hydroxide of vitamin D3 ingestion on upper respiratory tract infection (URTI). DESIGN AND SETTING: A prospective, randomized, double-blind, placebo-controlled study was performed from December 2015 to September 2016 in the Nihonbashi Egawa Clinic, Kei Medical Office TOC Building Medical Clinic, and Medical Corporation Kaiseikai Kita-Shinyokohama Medical Clinic, in Japan. PARTICIPANTS: Four hundred twenty eight participants aged 45-74 years were screened by their serum 25-hydoroxyvitamin D concentration. INTERVENTION: The participants were randomized to either 25OHD (10 µg/day) or placebo capsule, daily, for 16 consecutive weeks. MEASUREMENTS: The primary outcome measure was the incidence proportion of URTI, and the secondary outcome measures were the physical severity score, the quality-of-life (QOL) score, the duration of URTI, and the incidence proportion of new URTI events every four weeks. Data were collected using cold diary Wisconsin Upper Respiratory Symptom Survey-21 (WURSS-21) during the intervention. RESULTS: Of 428 participants screened, 252 with serum 25-hydroxyvitamn D levels were deficient or insufficient (75 nmol/L or less) were enrolled in this study. Of these, 105 placebo and 110 25OHD group subjects completed the study. For the incidence proportion of URTI, no effect of 25OHD intake was observed. On the other hand, the duration of URTI was shorter in the 25OHD (P = 0.061) compared to placebo. For the incidence proportion of URTI every four weeks, the incidence of new URTI was decreased in both groups over the time of intake. However, when the 25OHD and the placebo were compared, a decrease in the incidence proportion of URTI was seen earlier in the 25OHD. When the total physical severity score and the total QOL score during the study were assessed, they both were significantly improved in the 25OHD compared to placebo. CONCLUSIONS: The intake of 25OHD may reduce the duration of URTI, the physical severity, and the QOL when suffering from URTI.


Asunto(s)
Suplementos Dietéticos/análisis , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Vitamina D/análogos & derivados , Anciano , Calcifediol/uso terapéutico , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Vitamina D/administración & dosificación , Vitamina D/farmacología , Vitamina D/uso terapéutico
2.
Water Sci Technol ; 72(12): 2187-93, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26676006

RESUMEN

Effects of physical and morphometric factors on nutrient removal properties were studied in small agricultural ponds with different depths, volumes, and residence times in western Japan. Average residence time was estimated to be >15 days, and it tended to decrease from summer to winter because of the increase in water withdrawal for agricultural activity. Water temperature was clearly different between the surface and bottom layers; this indicates that thermal stratification occurred in summer. Chlorophyll-a was significantly high (>20 µg/L) in the surface layer (<0.5 m) and influenced by the thermal stratification. Removal ratios of dissolved total nitrogen (DTN) and dissolved total phosphorus in the ponds were estimated to be 53-98% and 39-98% in August and 10-92% and 36-57% in December, respectively. Residence time of the ponds was longer in August than in December, and DTN removal, in particular, was more significant in ponds with longer residence time. Our results suggest residence time is an important factor for nitrogen removal in small agricultural ponds as well as large lakes.


Asunto(s)
Agricultura , Nitrógeno/análisis , Fósforo/análisis , Estanques/química , Agricultura/métodos , Clorofila/análisis , Clorofila A , Conductividad Eléctrica , Japón , Lluvia , Estaciones del Año , Temperatura , Factores de Tiempo
3.
J Biol Regul Homeost Agents ; 28(3): 433-42, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25316130

RESUMEN

Pirfenidone is an antifibrotic agent for patients with pulmonary fibrosis, but this drug has adverse gastrointestinal (GI) effects. The first aim of this study was to assess GI symptoms due to pirfenidone by using a new questionnaire for reflux symptoms and dismotility symptoms. Whether adding herbal medicine of rikkunshi-to improved GI symptoms due to pirfenidone therapy was also investigated. This was a randomized controlled trial performed on 17 IPF patients. The patients were assigned to two groups, and the study period was 8 weeks. The pirfenidone group received pirfenidone therapy for 8 weeks with add-on rikkunshi-to from 4 weeks, while the control group did not receive either of these agents. To assess the effects of RK, plasma levels of acyl-ghrelin and des-acyl-ghrelin, serum KL-6 and surfactant protein-D, and pulmonary function tests were monitored. GI symptoms were most severe during the initial 2 weeks of pirfenidone therapy at a dose of 600 mg/day. Both reflux symptoms and dismotility symptoms deteriorated. Rikkunshi-to improved GI symptoms to the level prior to pirfenidone therapy. Plasma levels of des-acyl-ghrelin and acyl-/des-acyl-ghrelin ratio changed significantly at 8 weeks compared to 2 weeks. GI adverse events due to PFD were most severe in the first 2 weeks of treatment at a dose of 600 mg/day, and both reflux and dismotility symptoms deteriorated, but the drug was well tolerated at 1200 mg/day. Rikkunshi-to contributed to improvement of GI symptoms, but plasma ghrelin levels did not reflect the improvement of GI symptoms.


Asunto(s)
Antiinflamatorios no Esteroideos , Medicamentos Herbarios Chinos , Reflujo Gastroesofágico , Fibrosis Pulmonar Idiopática/tratamiento farmacológico , Piridonas , Anciano , Anciano de 80 o más Años , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/efectos adversos , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/efectos adversos , Femenino , Reflujo Gastroesofágico/sangre , Reflujo Gastroesofágico/inducido químicamente , Reflujo Gastroesofágico/fisiopatología , Ghrelina/sangre , Humanos , Fibrosis Pulmonar Idiopática/sangre , Fibrosis Pulmonar Idiopática/fisiopatología , Masculino , Persona de Mediana Edad , Mucina-1/sangre , Piridonas/administración & dosificación , Piridonas/efectos adversos , Encuestas y Cuestionarios , Factores de Tiempo
4.
Rhinology ; 52(3): 252-9, 2014 09.
Artículo en Inglés | MEDLINE | ID: mdl-25271531

RESUMEN

OBJECTIVE: To determine the mechanisms by which a traditional herbal medicine, Senkinnaidakusan (SKNS), controls Th2 responses, we examined the production of IL-12 by murine macrophages treated with SKNS. RESULTS: Treatment with SKNS significantly increased TLR4 mRNA in macrophages. Furthermore, pre-treatment with SKNS enhanced the production of IL-12 by macrophages stimulated with LPS. When SKNS was orally administered to C3H/HeN mice at the induction phase after OVA sensitization, the serum levels of OVA-specific immunoglobulin (Ig)E and IgG1 decreased, Interleukin (IL)-4 production by spleen T cells in response to OVA was significantly suppressed, while interferon (IFN)-gamma production was increased. After nasal challenge of OVA, eosinophilic infiltration in the nasal mucosa and the number of sneezes were significantly inhibited in SKNS-treated mice compared with control mice. Besides, expression of IL-5 in the nasal mucosa was also inhibited. Using another strain of mice, C3H/HeJ (TLR4 negative), there was no difference in OVA-specific Igs or splenic cytokine production between the SKNS treatment and non-treatment groups. The eosinophilic infiltration in the nasal mucosa, the number of sneezes and IL-5 expression in the nasal mucosa were also not effected even after SKNS treatment. CONCLUSION: These results suggest that oral administration of SKNS inhibits Th2 responses by enhancement of IL-12 release from macrophages via up-regulation of TLR4 expression.


Asunto(s)
Interleucina-12/biosíntesis , Macrófagos/metabolismo , Medicina Tradicional de Asia Oriental , Rinitis Alérgica Perenne/metabolismo , Rinitis Alérgica Perenne/terapia , Receptor Toll-Like 4/genética , Animales , Línea Celular , Modelos Animales de Enfermedad , Femenino , Lipopolisacáridos/farmacología , Ratones , Ratones Endogámicos C3H , ARN Mensajero/metabolismo , Rinitis Alérgica , Receptor Toll-Like 4/metabolismo , Regulación hacia Arriba
5.
Water Sci Technol ; 66(10): 2194-201, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22949251

RESUMEN

Increased population growth and food prices have resulted in more demand for fertilizers, especially phosphorus (P), to be used in agriculture and production of food crops. Phosphorus is one of the important natural resources and will be exhausted in the near future. Nowadays, struvite production is a good method to recover P from urine. However, the natural urines contain high amounts of micro-organic pollutants which may cause health risks. Therefore, in this contribution, we investigated the amount of micro-organic pollutants in struvite from urine. There are various kinds of pharmaceuticals and hormones which are used in the world. Nevertheless, we focused on 10 pharmaceuticals (amoxycillin, carbamazepine, erythromycin, furosemide, atenolol, ibuprofen, norfloxacin, trimethoprim, tetracycline, and acetylsalicylic acid) and one hormone (17ß-estradiol) as representatives. The experiments were carried out with synthetic and natural urines. After the production of struvite, the results from synthetic and natural urine samples showed that only tetracycline, erythromycin, and norfloxacin remained in the struvite, and, especially, tetracycline remained in struvite with quite a high amount.


Asunto(s)
Fósforo/química , Orina/química , Eliminación de Residuos Líquidos/métodos , Contaminantes Químicos del Agua/química , Compuestos de Magnesio/química , Estructura Molecular , Preparaciones Farmacéuticas/química , Fosfatos/química , Reproducibilidad de los Resultados , Estruvita
6.
J Int Med Res ; 34(5): 495-504, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17133778

RESUMEN

Fexofenadine, a histamine H1-receptor antagonist, is approved for the treatment of pruritus associated with atopic dermatitis. The effects of fexofenadine on scratching behaviour, and plasma levels of histamine and eotaxin were assessed in a new model of atopic dermatitis. Mice fed a diet low in Mg2+ and Zn2+ (special diet S) were compared with mice on a normal diet (N) or diet S plus fexofenadine HCl for weeks 0-10 (S + F(0-10)), 0-5 (S + F(0-5)) or 6 - 10 (S + F(6-10)) (seven mice per group). Compared with group N, group S mice showed significantly greater scratching frequency, and plasma histamine and eotaxin concentrations; these three variables were significantly lower in group S + F(0-10) than in group S. Scratching frequency increased when fexofenadine was discontinued. Fexofenadine significantly reduced mast cell and eosinophil numbers. Histamine may be important in the pathological changes seen in this model of atopic dermatitis, suggesting that it might aid future development of antihistamines for the treatment of atopic dermatitis.


Asunto(s)
Dermatitis Atópica/tratamiento farmacológico , Prurito/tratamiento farmacológico , Terfenadina/análogos & derivados , Animales , Recuento de Células , Quimiocina CCL11 , Quimiocinas CC/sangre , Dermatitis Atópica/sangre , Dermatitis Atópica/patología , Dieta , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Eosinófilos/efectos de los fármacos , Eosinófilos/patología , Histamina/sangre , Magnesio/administración & dosificación , Mastocitos/efectos de los fármacos , Mastocitos/patología , Ratones , Prurito/sangre , Prurito/patología , Terfenadina/farmacología , Zinc/administración & dosificación
7.
Water Sci Technol ; 54(8): 247-55, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17163034

RESUMEN

Interest in phosphorus recovery from urine diverted from faeces has been growing recently. Phosphorus in urine can be precipitated out as struvite (MgNH4PO4 x 6H2O) with addition of magnesium salt under alkaline conditions. Struvite formation, however, should be more well understood for its practical application. We predicted the struvite formation with a development of a new equilibrium model. The model considered the formation of eight different kinds of precipitates, including struvite, with effects of ionic strength and temperature. In addition, experiments on struvite formation in urine were conducted for the model validation. The model prediction of struvite formation had good agreement with the experimental results. The optimum pH to form struvite was predicted to be 9.4-9.7. In order to precipitate 99% of phosphate in urine with 1.5 fold Mg concentration to PO4-P, the pH value was necessary to be more than 8.1 based on the model prediction.


Asunto(s)
Compuestos de Magnesio/orina , Modelos Biológicos , Fosfatos/orina , Fósforo/orina , Humanos , Magnesio/metabolismo , Concentración Osmolar , Estruvita , Temperatura
8.
Water Sci Technol ; 53(6): 107-13, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16749446

RESUMEN

A new biological nutrient removal process, anaerobic-oxic-anoxic (A/O/A) system using denitrifying polyphosphate-accumulating organisms (DNPAOs), was proposed. To attain excess sludge reduction and phosphorus recovery, the A/O/A system equipped with ozonation tank and phosphorus adsorption column was operated for 92 days, and water quality of the effluent, sludge reduction efficiency, and phosphorus recovery efficiency were evaluated. As a result, TOC, T-N and T-P removal efficiency were 85%, 70% and 85%, respectively, throughout the operating period. These slightly lower removal efficiencies than conventional anaerobic-anoxic-oxic (A/A/O) processes were due to the unexpected microbial population in this system where DNPAOs were not the dominant group but normal polyphosphate-accumulating organisms (PAOs) that could not utilize nitrate and nitrite as electron acceptor became dominant. However, it was successfully demonstrated that 34-127% of sludge reduction and around 80% of phosphorus recovery were attained. In conclusion, the A/O/A system equipped with ozonation and phosphorus adsorption systems is useful as a new advanced wastewater treatment plant (WWTP) to resolve the problems of increasing excess sludge and depleted phosphorus.


Asunto(s)
Reactores Biológicos , Fósforo/química , Polifosfatos/química , Aguas del Alcantarillado , Eliminación de Residuos Líquidos/métodos , Purificación del Agua/métodos , Adsorción , Genes Bacterianos , Hibridación Fluorescente in Situ , Nitritos , Ozono , Factores de Tiempo , Circonio/química
9.
Environ Technol ; 27(1): 95-102, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16457179

RESUMEN

The objective of this study was to investigate the biodegradation of coal-derived hydrocarbons, especially high molecular weight (HMW) components, under anaerobic conditions. For this purpose biodegradation experiments were performed, using specifically designed soil column bioreactors. For the experiment, coal-contaminated soil was prepared, which contains high molecular weight hydrocarbons at high concentration (approx. 55.5 mgC g-drysoil(-1)). The experiment was carried out in two different conditions: sulfate reducing (SR) condition (SO4(2-) = 10 mmol l(-1) in the liquid medium) and control condition (SO4(2-)<0.5 mmol l(-1)). Although no degradation was observed under the control condition, the resin fraction decreased to half (from 6,541 to 3,386 mgC g-soil(-1)) under SR condition, with the concomitant increase of two PAHs (phenanthrene and fluoranthene, 9 and 2.5 times, respectively). From these results, we could conclude that high molecular hydrocarbons were biodegradable and transformed to low molecular weight PAHs under the sulfate-reducing condition. Since these PAHs are known to be biologically degraded under aerobic condition, a serial combination of anaerobic (sulfate reducing) and then aerobic bioremediations could be effective and useful for the soil pollution by petroleum and/or coal derived hydrocarbons.


Asunto(s)
Carbón Mineral , Hidrocarburos Policíclicos Aromáticos/metabolismo , Contaminantes del Suelo/metabolismo , Bacterias Reductoras del Azufre/fisiología , Contaminantes Químicos del Agua/metabolismo , Anaerobiosis , Biodegradación Ambiental , Reactores Biológicos , Sedimentos Geológicos/química , Sedimentos Geológicos/microbiología , Peso Molecular , Petróleo , Microbiología del Suelo , Factores de Tiempo
10.
Water Sci Technol ; 52(12): 225-32, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16477990

RESUMEN

We installed a new device on a paved road to treat runoff from a roadway surface. All the stormwater runoff was transferred into the device and the runoff equivalent to 10 mm/hr or less was treated. The treatment method consists of sedimentation and up-flow filtration with porous polypropylene (PPL) processes. The treated runoff was discharged into the existing storm drainage pipe. The average removal efficiency of the initial runoff at the beginning of rainfall which has high pollution intensity was about 90% for SS, about 70% for COD, about 40% for total phosphorus (T-P), about 80% for Pb and Cd, about 70% for Zn, Cu, Mn and Cr, and about 60% for polycyclic aromatic hydrocarbons (PAHs). The overall removal efficiencies of the experiment that ran for four months remained > 60% of SS, > 40% of COD, > 60% of heavy metals, and > 40% of PAHs. The PPL is excellent for removing smaller size particulates of suspended solids, which originate basically from diesel exhaust, as well as larger size particulates from automobile tires, asphalt roads, and other accumulated source(s) of clay and sand, etc.


Asunto(s)
Monitoreo del Ambiente , Polipropilenos/química , Emisiones de Vehículos , Contaminantes del Agua/aislamiento & purificación , Purificación del Agua/métodos , Ciudades , Filtración , Metales/aislamiento & purificación , Oxígeno/química , Oxígeno/metabolismo , Tamaño de la Partícula , Fósforo/aislamiento & purificación , Hidrocarburos Policíclicos Aromáticos/aislamiento & purificación , Porosidad , Factores de Tiempo , Movimientos del Agua
11.
Res Vet Sci ; 77(2): 123-9, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15196902

RESUMEN

The aim of this study was to elucidate the mechanisms underlying the hypoglycaemic effect of N. sativa oil (Nigella sativa oil) in streptozotocin (STZ)-induced diabetic hamsters, in terms of hepatic glucose production, and to investigate the possible immunopotentiating effect of N. sativa oil on peritoneal macrophages. Diabetes was induced by intraperitoneal injection of 65 mg/kg body weight of STZ. Treatment with N. sativa oil commenced 6 weeks after induction of diabetes at a dose of 400 mg/kg body weight by gastric gavage. Isolated hepatocytes were collected using collagenase to determine liver glucose production. Phagocytic activity was evaluated by injection of fluorescent latex (2 microm diameter) intraperitoneally, followed 24 h later by collection of peritoneal macrophages. N. sativa oil reduced blood glucose from 391+/-3.0 mg/dl before treatment to 325+/-4.7, 246+/-5.9, 208+/-2.5 and 179+/-3.1 mg/dl after the first, second, third and fourth weeks of treatment, respectively. Hepatic glucose production from gluconeogenic precursors (alanine, glycerol and lactate) was significantly lower in treated hamsters. Treatment with N. sativa oil significantly increased the phagocytic activity and phagocytic index of peritoneal macrophages and lymphocyte count in peripheral blood compared with untreated diabetic hamsters. Our data indicate that the hypoglycaemic effect of N. sativa oil is due to, at least in part, a decrease in hepatic gluconeogenesis, and that the immunopotentiating effect of N. sativa oil is mediated through stimulation of macrophage phagocytic activity either directly or via activation of lymphocytes.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Diabetes Mellitus Experimental/metabolismo , Gluconeogénesis/efectos de los fármacos , Hipoglucemia/metabolismo , Hipoglucemiantes/farmacología , Hígado/efectos de los fármacos , Aceites de Plantas/farmacología , Animales , Glucemia/metabolismo , Cricetinae , Glucosa/metabolismo , Hemoglobina Glucada/metabolismo , Inyecciones Intraperitoneales/veterinaria , Recuento de Leucocitos/veterinaria , Hígado/metabolismo , Activación de Linfocitos/efectos de los fármacos , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/fisiología , Masculino , Mesocricetus , Fagocitosis/fisiología
12.
Res Vet Sci ; 73(3): 279-82, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12443686

RESUMEN

The present study was designed to investigate the possible insulinotropic properties of Nigella sativa L. (N. sativa) oil in Streptozotocin plus Nicotinamide-induced diabetes mellitus in hamsters. Nicotinamide was injected intraperitoneally 15min before injection of Streptozotocin intravenously. Oral treatment with N. sativa oil began 4 weeks after induction of diabetes. Serum insulin was measured by enzymeimmunoassay. Islets insulin was stained using anti-insulin monoclonal antibody. Significant decrease in blood glucose level together with significant increase in serum insulin level were observed after treatment with N. sativa oil for 4 weeks. Big areas with positive immuno-reactivity for the presence of insulin were observed in the pancreases from N. sativa oil-treated group compared to non-treated one using immunohistochemical staining. Therefore, our data show that the hypoglycemic effect of N. sativa oil in Streptozotocin plus Nicotinamide diabetic hamsters resulted, at least partly, from a stimulatory effect on beta cell function with consequent increase in serum insulin level. These results indicate that N. sativa oil has insulinotropic properties in type 2-like model.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Insulina/metabolismo , Aceites de Plantas/farmacología , Animales , Glucemia/metabolismo , Cricetinae , Inmunohistoquímica , Insulina/sangre , Masculino , Mesocricetus , Niacinamida/administración & dosificación , Páncreas/metabolismo , Estreptozocina/administración & dosificación
13.
Int Immunopharmacol ; 2(11): 1603-11, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12433061

RESUMEN

The objective of the present study was to determine the immunomodulatory role of thymoquinone (TQ) regarding its effect on the production of nitric oxide (NO) by rat peritoneal macrophages. Under certain conditions, macrophagesand certain other cells can produce high concentrations of NO from its precursor L-arginine via inducible nitricoxide synthase (iNOS)pathway. TQ has been established as the major component of the oil extracted from Nigella saliva plant seeds, which is being used frequently in herbal medicine. TQ (IC50 1.4-2.76 microM) dose- and time-dependently reduced nitrite production, a parameter for NO synthesis, in supematants of lipopolysaccharide (LPS)-stimulated (5 microg/ml) macrophages without affecting the cell viability. The protein level of iNOS in peritoneal macrophages was also decreased by TQ in a concentration-dependent manner. In addition, TQ inhibited the increase in iNOS mRNA expression induced by LPS indicated by reverse transcription-polymerase chain reaction (RT-PCR). These inhibitory effects of TQ were confirmed by immunofluorescence staining of iNOS in macrophages which showed decreased immunoreactivity for iNOS after treatment with TQ if compared with the control LPS-stimulated cells. These results suggest that TQ suppresses the production of NO by macrophages; an effect which may be useful in ameliorating the inflammatory and autoimmune conditions.


Asunto(s)
Benzoquinonas/farmacología , Macrófagos Peritoneales/enzimología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/biosíntesis , Animales , Western Blotting , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Relación Dosis-Respuesta a Droga , Inmunohistoquímica , Técnicas In Vitro , Indicadores y Reactivos , Macrófagos Peritoneales/efectos de los fármacos , Masculino , Óxido Nítrico Sintasa de Tipo II , ARN Mensajero/biosíntesis , ARN Mensajero/aislamiento & purificación , Ratas , Ratas Endogámicas OLETF , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
14.
Helicobacter ; 7(5): 306-9, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12390210

RESUMEN

BACKGROUND: Primary and acquired resistance to the antimicrobial agents is a primary reason for the failure of Helicobacter pylori eradication therapies. We assessed the primary antibiotic resistance rates of H. pylori to three different antibiotics and its relationship due to the annual antibiotic consumption in Japan during the period prior to approval of anti-H. pylori therapy in Japan. MATERIALS AND METHODS: Antibiotic susceptibility was tested using the agar dilution method for clarithromycin, amoxicillin and metronidazole. Isolates were considered resistant when the MIC value was > 8 mg/l for metronidazole, > 1 mg/l for clarithromycin and < 0.5 mg/l for amoxicillin. RESULTS: Helicobacter pylori isolates were obtained from 593 Japanese patients from 1995 to 2000. Primary resistance of H. pylori to clarithromycin, metronidazole and amoxicillin was found in 11%, 9% and 0.3% strains, respectively. The proportion with clarithromycin resistance significantly increased from 7% in 1997-98 to 15.2% in 1999-2000 (p =.003). During the same period the metronidazole resistance rate also increased from 6.6% in 1997-98 to 12% in 1999-2000 (p =.02). The prevalence of clarithromycin and metronidazole was related to the annual consumption of these antimicrobial agents. CONCLUSION: Resistance rates for both clarithromycin and metronidazole appear to reflect the annual consumption of these agents. The high rate of clarithromycin resistance in Japan suggests that the effectiveness of clarithromycin-based therapies may be compromised in the near future.


Asunto(s)
Antibacterianos/uso terapéutico , Claritromicina/uso terapéutico , Farmacorresistencia Bacteriana , Infecciones por Helicobacter/epidemiología , Helicobacter pylori/efectos de los fármacos , Metronidazol/uso terapéutico , Antibacterianos/farmacología , Claritromicina/farmacología , Femenino , Infecciones por Helicobacter/tratamiento farmacológico , Humanos , Masculino , Metronidazol/farmacología , Pruebas de Sensibilidad Microbiana , Prevalencia
15.
Methods Find Exp Clin Pharmacol ; 24(2): 67-70, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12040884

RESUMEN

Human Toll-like receptor 4 (TLR4) has recently been identified and has been shown to be the main protein involved in recognizing Gram-negative bacteria. We examined the regulation of TLR4 surface expression in a human monocytic cell line (THP-1 cells) by two traditional Chinese herbal medicines. Bu-Zhong-Yi-Qi-Tang (TJ-41) and Shi-Quan-Da-Bu-Tang (TJ-48). TJ-41 and TJ-48 upregulated TLR4 surface expression in THP-1 cells, as well as enhanced TLR4 surface expression in these cells both dose- and time-dependently. These findings suggest that TJ-41 and TJ-48 increase the receptor involved in the response to Gram-negative bacteria and may enhance defenses against these pathogens.


Asunto(s)
Proteínas de Drosophila , Medicamentos Herbarios Chinos/farmacología , Glicoproteínas de Membrana/biosíntesis , Monocitos/metabolismo , Receptores de Superficie Celular/biosíntesis , Animales , Línea Celular , Relación Dosis-Respuesta a Droga , Humanos , Ratones , Monocitos/citología , Factores de Tiempo , Receptor Toll-Like 4 , Receptores Toll-Like , Regulación hacia Arriba
16.
J Biomed Mater Res ; 58(6): 658-65, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11745518

RESUMEN

The ability of an albumin-based hydrogel sealant (ABHS) to prevent air leakage through the suture line after pulmonary surgery was evaluated by comparison with that of a fibrin glue (FG). As an air-leak model, a rat lung was used in which a standard incision was made and the burst pressure for ABHS and FG was measured. The average burst pressures at time 0 for the FG and ABHS groups were 30.8+/-15.2 and 77.5 +/-19.1 mmHg, respectively. At Day 3, the value of ABHS (76.3 +/- 15.8 mmHg) was still significantly higher (P<0.05) than that of FG (60.0 +/- 21.9 mmHg). At Day 7, no statistical difference was observed between the FG group(71.2 +/- 18.6 mmHg) and the ABHS group(88.8 +/- 11.7 mmHg). Histological examination of the incision at Day 14 revealed that neither sealant was not visible at the incision site, and there was no evidence of adverse tissue reaction. It was concluded that ABHS had good sealing properties and is an alternative to FG for air leakage treatment in pulmonary surgery.


Asunto(s)
Aire , Pulmón/cirugía , Polietilenglicoles/uso terapéutico , Albúmina Sérica/uso terapéutico , Succinatos/uso terapéutico , Toracotomía/efectos adversos , Adhesivos Tisulares/uso terapéutico , Animales , Reactivos de Enlaces Cruzados , Evaluación Preclínica de Medicamentos , Adhesivo de Tejido de Fibrina , Humanos , Pulmón/patología , Lesión Pulmonar , Modelos Animales , Presión , Ratas , Ratas Wistar , Técnicas de Sutura
17.
Nat Biotechnol ; 19(8): 751-5, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11479568

RESUMEN

We have developed a protein-synthesizing system reconstituted from recombinant tagged protein factors purified to homogeneity. The system was able to produce protein at a rate of about 160 microg/ml/h in a batch mode without the need for any supplementary apparatus. The protein products were easily purified within 1 h using affinity chromatography to remove the tagged protein factors. Moreover, omission of a release factor allowed efficient incorporation of an unnatural amino acid using suppressor transfer RNA (tRNA).


Asunto(s)
Sistema Libre de Células , Proteínas Recombinantes/metabolismo , Aminoácidos/química , Cromatografía de Afinidad , Electroforesis en Gel de Poliacrilamida , Escherichia coli/metabolismo , Histidina/química , Plásmidos/metabolismo , Biosíntesis de Proteínas , ARN de Transferencia/metabolismo , Aminoacil-ARN de Transferencia/metabolismo , Ribosomas/metabolismo , Factores de Tiempo
18.
Exp Biol Med (Maywood) ; 226(6): 577-80, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11395929

RESUMEN

The aim of this study was to find an inactivating substance for tetanus toxin in natural foodstuff. Tetanus toxin (4 micrograms/ml) abolished indirect twitches in In vitro mouse phrenic nerve-diaphragm preparations within 2.5 hr. Hot water infusion of black tea mixed with tetanus toxin blocked the inhibitory effect of the toxin. Mixing the toxin with thearubigin fraction extracted from black tea infusion produced an identical result. Furthermore, thearubigin fraction mixed with the toxin protected against the in vivo paralytic effect of the toxin. Thearubigin fraction had no protective effect on other toxins, such as tetrodotoxin and saxitoxin. The specific binding of [125I]tetanus toxin to rat cerebrocortical synaptosomes was inhibited by mixing iodinated toxin with thearubigin fraction. These results imply that thearubigin fraction counteracts the effect of tetanus toxin by binding with toxin, and also suggest that this fraction may be able to apply for prophylaxis of tetanus.


Asunto(s)
Catequina/análogos & derivados , , Toxina Tetánica/antagonistas & inhibidores , Animales , Fraccionamiento Químico , Femenino , Masculino , Ratones , Fenoles , Extractos Vegetales/farmacología , Polifenoles , Ratas , Ratas Wistar , Té/química
19.
Br J Pharmacol ; 132(4): 797-8, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11181419

RESUMEN

Botulinum neurotoxin type A (BoNT/A, 1.5 nM) completely inhibited indirectly evoked twitches in in vitro mouse phrenic nerve-diaphragm preparations within 40 - 45 min. Black tea extract, thearubigin fraction (TRB), mixed with BoNT/A blocked the inhibitory effect of the toxin. The protective effect of TRB extended to botulinum neurotoxins types B and E (BoNT/B and BoNT/E) and tetanus toxin, but not to tetrodotoxin. TRB was also effective against oral toxicity of BoNT/A, B and E. Thus, TRB may be of potential benefit in protecting the paralytic actions of botulinum neurotoxins (BoNTs), but its use is limited by mixing with the toxin.


Asunto(s)
Toxinas Botulínicas Tipo A/toxicidad , Catequina/análogos & derivados , Catequina/farmacología , Fenoles/farmacología , , Animales , Femenino , Técnicas In Vitro , Masculino , Ratones , Unión Neuromuscular/efectos de los fármacos , Unión Neuromuscular/fisiología , Extractos Vegetales/farmacología , Polifenoles
20.
J Gastroenterol Hepatol ; 15(8): 849-59, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11022824

RESUMEN

BACKGROUND: Although branched-chain aminoacids (BCAA) are reported to be effective in prolongation of the mean survival time of patients with liver cirrhosis, it is not clear whether BCAA could influence the immune function in those patients. METHODS: Branched-chain amino acids were given as a supplement to carbon tetrachloride-induced cirrhotic rats, and an aminogram of the liver and kinetics of liver-associated lymphocytes (LAL) were then analysed. RESULTS: Liver cirrhosis was established at the 12th week, and glutathione S-transferase placental form (GST-P)-positive lesions, which are known to be pre-neoplastic lesions, occupied 1.72+/-0.84% of the liver at the 16th week in the controls. At this time the LAL showed an increase in the number of CD5-, CD8- and CD18-positive cells and augmentation of lectin-dependent cellular cytotoxicity (LDCC) activity. Furthermore, supplementation of BCAA increased the number of LAL, especially CD8-positive cells and natural killer cells, and augmented LDCC activity of LAL at the 16th week. The number of LAL was positively correlated with the valine concentration in the plasma and liver, and the area of GST-P-positive lesions tended to be decreased in the BCAA group. CONCLUSION: These findings suggest that BCAA administration has stimulatory effects on the local immune systems of the liver, which may have a potential to inhibit hepatocarcinogenesis. Moreover, among all amino acids valine might be an important amino acid for enhancing the immune function of LAL.


Asunto(s)
Aminoácidos de Cadena Ramificada/farmacología , Cirrosis Hepática Experimental/dietoterapia , Cirrosis Hepática Experimental/inmunología , Linfocitos/efectos de los fármacos , Aminoácidos de Cadena Ramificada/análisis , Animales , Tetracloruro de Carbono , Citometría de Flujo , Glutatión Transferasa/análisis , Técnicas para Inmunoenzimas , Hígado/citología , Cirrosis Hepática Experimental/patología , Linfocitos/inmunología , Masculino , Lesiones Precancerosas/dietoterapia , Lesiones Precancerosas/inmunología , Lesiones Precancerosas/patología , Ratas , Ratas Endogámicas F344 , Estadísticas no Paramétricas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA